Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasis

Cancer Science

Volumn 103, Issue 7, 2012, Pages 1342-1347

  Matsumura, Yuki ^a,b   Ishii, Genichiro ^a   Aokage, Keiju ^a,b   Kuwata, Takeshi ^a   Hishida, Tomoyuki ^b   Yoshida, Junji ^b   Nishimura, Mitsuyo ^b   Nagai, Kanji ^b   Ochiai, Atsushi ^a  

^a National Cancer Center   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GEMININ; HERMES ANTIGEN; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER PATIENT; CELL INFILTRATION; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LUNG ADENOCARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPH VESSEL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR MICROENVIRONMENT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CADHERINS; CASPASE 3; CELL CYCLE PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SCAVENGER RECEPTORS, CLASS A; STROMAL CELLS; TUMOR MICROENVIRONMENT; YOUNG ADULT;

EID: 84863309941     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02275.x     Document Type: Article

References (26)

1. Aokage K, Ishii G, Ohtaki Y et al. Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation. Int J Cancer 2010; 128: 1585-95.
2. Saijo T, Ishii G, Ochiai A et al. Evaluation of extratumoral lymphatic permeation in non-small cell lung cancer as a means of predicting outcome. Lung Cancer 2007; 55: 61-6.
3. Sakuma Y, Takeuchi T, Nakamura Y et al. Lung adenocarcinoma cells floating in lymphatic vessels resist anoikis by expressing phosphorylated Src. J Pathol 2010; 220: 574-85.
4. Ishii G, Ito TK, Aoyagi K et al. Presence of human circulating progenitor cells for cancer stromal fibroblasts in the blood of lung cancer patients. Stem Cells 2007; 25: 1469-77.
5. Duda DG, Duyverman AM, Kohno M et al. Malignant cells facilitate lung metastasis by bringing their own soil. Proc Natl Acad Sci USA 2010; 107: 21677-82.
6. Girard N, Deshpande C, Lau C et al. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am J Surg Pathol 2009; 33: 1752-64.
7. Union for International Cancer Control (UICC). TNM Classification of Malignant Tumours, 6th edn. Geneva: UICC, 2002.
8. Travis W, Coblby T, Corrin B, Shimosato Y, Brambilla E. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, 3rd edn. Berlin: Springer Verlag, 1999.
9. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68: 3645-54.
10. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-54.
11. Wells A, Yates C, Shepard CR. E-Cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis 2008; 25: 621-8.
12. Ono K, Sugio K, Uramoto H et al. Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer-related proteins. Cancer 2009; 115: 3489-500.
13. Imai T, Horiuchi A, Shiozawa T et al. Elevated expression of E-cadherin and alpha-, beta-, and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas. Hum Pathol 2004; 35: 1469-76.
14. Kowalski PJ, Rubin MA, Kleer CG. E-Cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 2003; 5: R217-22.
15. Yates CC, Shepard CR, Stolz DB, Wells A. Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer 2007; 96: 1246-52.
16. Mamoune A, Kassis J, Kharait S et al. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Exp Cell Res 2004; 299: 91-100.
17. Kargi HA, Kuyucuoglu MF, Alakavuklar M, Akpinar O, Erk S. CD44 expression in metastatic and non-metastatic non-small cell lung cancers. Cancer Lett 1997; 119: 27-30.
18. Sheridan C, Kishimoto H, Fuchs RK et al. CD44 + /CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006; 8: R59.
19. Singleton PA, Salgia R, Moreno-Vinasco L et al. CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin. J Biol Chem 2007; 282: 30643-57.
20. Valentiner U, Valentiner FU, Schumacher U. Expression of CD44 is associated with a metastatic pattern of human neuroblastoma cells in a SCID mouse xenograft model. Tumour Biol 2008; 29: 152-60.
21. Tomlinson JS, Alpaugh ML, Barsky SH. An intact overexpressed E-cadherin/alpha, beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res 2001; 61: 5231-41.
22. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000; 6: 100-2.
23. Wei L, Yang Y, Zhang X, Yu Q. Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene 2004; 23: 9052-61.
24. Windham TC, Parikh NU, Siwak DR et al. Src activation regulates anoikis in human colon tumor cell lines. Oncogene 2002; 21: 7797-807.
25. Ohtaki Y, Ishii G, Nagai K et al. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma. J Thorac Oncol 2010; 10: 1507-15.
26. Zhang Q, Yang M, Shen J, Gerhold LM, Hoffman RM, Xing HR. The role of the intravascular microenvironment in spontaneous metastasis development. Int J Cancer 2010; 126: 2534-41.